26th Annual San Diego Heart Failure Symposium


26th Annual San Diego Heart Failure Symposium

presented by 26th Annual San Diego Heart Failure Symposium

11 others would like to attend.

I need an invite

Notification icon Saturday, September 26, 2020 8 AM - 5 PM America/Los_Angeles

Event info

Register HERE!


The 26th Annual San Diego Heart Failure Symposium, which will be held virtually, continues in the tradition of our past programs in providing registrants an update on the latest and most exciting advances in the management of heart failure through a series of didactic lectures. Topics that will be covered extend from preventing heart failure by managing risk factors such as hypertension, diabetes and hyperlipidemia to treating heart failure throughout all its stages. Key areas that will be covered include management of sleep disordered breathing, use of biomarkers, treatment of pulmonary artery hypertension, new uses of DOACs, and prevention of sudden death. We will provide an overview of the drugs used to treat heart failure and in the annual debate tackle the issue of how do we integrate all of these agents into the therapeutic regimen. The Symposium also covers use of percutaneous mechanical circulatory support, percutaneous treatment of valve lesions, use of remote monitoring, management of patients with advanced heart failure using LVADs and heart transplantation, as well as exciting new approaches for treating amyloid cardiomyopathy. New drugs for the treatment of heart failure will be discussed.


At the conclusion of this program, the participant should be able to:

  1. Summarize current and emerging treatments for heart failure, describe new guideline updates and provide practical information to help in the implementation of recommended therapies in individual patients;

  2. Review strategies for implementing medical and device therapies that will enhance prevention and lead to improved outcomes in heart failure patients;

  3. Describe the impact of COVID-19 on the management of patients with heart failure;

  4. Define how specific populations including minorities, women and the elderly respond to various approaches to treating hypertension and heart failure.


The target audience for this activity includes cardiologists, internists, primary care physicians, nurses and allied healthcare professionals.


This live activity, 26th Annual San Diego Heart Failure Symposium, with a beginning date of 09/26/2020, has been reviewed and is acceptable for up to 6.75 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician's Recognition Award.

AANP: The American Academy of Nurse Practitioners accepts AAFP Prescribed credit. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

ANCC: According to the ANCC, the continuing education hours approved by the AAFP meet the ANCC-accredited CNE criteria.

AAPA: The American Academy of Physician Assistants accepts AAFP Prescribed credit for AAPA Category 1 CME credit.

  • Barry Greenberg

    Program Director

11 others would like to attend.

I need an invite

Login to view comments. Click here to Login